2021
DOI: 10.28991/scimedj-2021-0301-6
|View full text |Cite
|
Sign up to set email alerts
|

The Domino Effect-Treatment of Superior Vena Cava Obstruction Triggering Tumor Lysis Syndrome: A Case Report

Abstract: Oncological emergencies present in a multitude of manners-structural, metabolic, hematologic, etc. affecting multiple systems, often. Urgent institution of therapy is often required for a successful outcome. Occasionally, the treatment of one emergency can initiate a related or unrelated emergency, necessitating management of all the complications simultaneously. Superior vena cava obstruction (SVCO) is a medical emergency and most often manifests in patients with a malignant disease process requiring immediat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
5
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 15 publications
(15 reference statements)
1
5
0
Order By: Relevance
“…In the past decades, great progress has been made in research on the pathogenesis of PCa [2]. With the development of diagnosis and treatment of PCa, the outcomes of patients have gained much improvement [3,4]. However, the challenge remains on the limited effective strategies.…”
Section: Introductionmentioning
confidence: 99%
“…In the past decades, great progress has been made in research on the pathogenesis of PCa [2]. With the development of diagnosis and treatment of PCa, the outcomes of patients have gained much improvement [3,4]. However, the challenge remains on the limited effective strategies.…”
Section: Introductionmentioning
confidence: 99%
“…However, many cases are usually refractory to treat surgically due to initial diagnosis at an advanced stage. Although advanced LIHC exists multiple treatments, including surgical excision, transarterial embolization, chemotherapy and radiofrequency ablation, the treatments effects are limited and LIHC still has a rate of recurrence as high as 70% [ 5 , 6 ]. In brief, patients with LIHC have a poor overall survival.…”
Section: Introductionmentioning
confidence: 99%
“…Correlating molecular marker signatures with outcome or chemoresistance can help unravel resistance mechanisms and identify predictive markers [ 97 ] for personalized medicine [ 18 , 98 , 99 ]. ProGENI found a correlation between the G2/M transition of the mitotic cell and resistance to doxorubicin in the nine analyzed cell lines.…”
Section: Discussionmentioning
confidence: 99%